IL166054A0 - Novel compounds pharmaceutical compositions containing same and methods of use for same - Google Patents

Novel compounds pharmaceutical compositions containing same and methods of use for same

Info

Publication number
IL166054A0
IL166054A0 IL16605403A IL16605403A IL166054A0 IL 166054 A0 IL166054 A0 IL 166054A0 IL 16605403 A IL16605403 A IL 16605403A IL 16605403 A IL16605403 A IL 16605403A IL 166054 A0 IL166054 A0 IL 166054A0
Authority
IL
Israel
Prior art keywords
same
methods
pharmaceutical compositions
compositions containing
novel compounds
Prior art date
Application number
IL16605403A
Other languages
English (en)
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of IL166054A0 publication Critical patent/IL166054A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
IL16605403A 2002-07-01 2003-07-01 Novel compounds pharmaceutical compositions containing same and methods of use for same IL166054A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39280902P 2002-07-01 2002-07-01
PCT/US2003/020960 WO2004006835A2 (en) 2002-07-01 2003-07-01 Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Publications (1)

Publication Number Publication Date
IL166054A0 true IL166054A0 (en) 2006-01-15

Family

ID=30115535

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16605403A IL166054A0 (en) 2002-07-01 2003-07-01 Novel compounds pharmaceutical compositions containing same and methods of use for same

Country Status (15)

Country Link
US (1) US20060241177A1 (ja)
EP (1) EP1534263A4 (ja)
JP (1) JP2005533107A (ja)
KR (1) KR20050072670A (ja)
CN (2) CN101633650A (ja)
AU (1) AU2003248810B2 (ja)
BR (1) BRPI0312413A2 (ja)
CA (1) CA2491183A1 (ja)
EA (1) EA010484B1 (ja)
HK (1) HK1086485A1 (ja)
IL (1) IL166054A0 (ja)
MX (1) MXPA05000152A (ja)
SG (1) SG170620A1 (ja)
WO (1) WO2004006835A2 (ja)
ZA (1) ZA200500203B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018737D0 (en) * 1990-08-28 1990-10-10 Goodfellow John W Phosphetic patellar components
EA007029B1 (ru) 2002-02-08 2006-06-30 Джон Хопкинс Юниверсити Скул Оф Медсин Стимуляция срт-1 как средство уменьшения веса
CA2491573A1 (en) * 2002-07-09 2004-01-15 Fasgen, Llc Methods of treating microbial infections in humans and animals
CN101007796A (zh) * 2006-01-27 2007-08-01 北京摩力克科技有限公司 新型五元杂环化合物及其制备方法和医疗用途
CN101190904A (zh) * 2006-11-23 2008-06-04 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸合成酶抑制剂及其制药用途
EP2581081A3 (en) 2007-06-01 2013-07-31 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
FR2957078B1 (fr) * 2010-03-05 2012-05-04 Centre Nat Rech Scient Acides paraconiques comme activateurs de pigmentation
WO2011140296A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
EP2566853B1 (en) 2010-05-05 2017-01-25 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
EP2892892B1 (en) * 2012-09-07 2017-05-31 Janssen Pharmaceutica NV Imidazolin-5-one derivatives useful as fatty acid synthase (fasn) inhibitors for the treatment of cancer
CN103145662B (zh) * 2013-02-18 2014-07-16 深圳万和制药有限公司 N-取代的氨基丁内酯衍生物及其用途
CN103864731B (zh) * 2014-02-19 2016-01-20 成都中医药大学 含季碳手性中心的呋喃内酯环类化合物的合成方法
CN104530018B (zh) * 2014-12-12 2017-04-12 郑州大学 含α‑亚甲基‑γ‑丁内酯结构的吲哚类化合物、制备方法及其应用
JP6626113B2 (ja) * 2015-02-05 2019-12-25 デルミラ インコーポレーテッド ２−（（２−エトキシ−２−オキソエチル）（メチル）アミノ）−２−オキソエチル５−テトラデシルオキシ）フラン−２−カルボキシレートを製造するための合成方法
KR102038971B1 (ko) * 2018-03-12 2019-11-26 주식회사 엔지켐생명과학 디아실글리세롤락톤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역증진제
KR20220159831A (ko) 2021-05-26 2022-12-05 울산과학기술원 미토콘드리아 표적화 뉴클레오펩티드 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496187A (en) * 1967-03-20 1970-02-17 American Home Prod N-(heterocyclyl)aconamides
US3472878A (en) * 1969-01-27 1969-10-14 American Home Prod N-(hydroxyaryl)aconamides
US4753871A (en) * 1986-12-12 1988-06-28 Eastman Kodak Company Cyan dye-forming couplers and photographic materials containing same
JPS63169848A (ja) * 1987-01-07 1988-07-13 Nec Corp デジタルデ−タ通信におけるデ−タ端末収容方式
JP2524760B2 (ja) * 1987-07-10 1996-08-14 テイカ株式会社 新規抗生物質
JPH04199148A (ja) * 1990-11-29 1992-07-20 Konica Corp ハロゲン化銀写真感光材料
JPH05246822A (ja) * 1992-03-07 1993-09-24 Nippon Paint Co Ltd 抗菌剤
JPH07112931A (ja) * 1993-08-27 1995-05-02 Nippon Paint Co Ltd エプスタイン−バーウイルス活性化抑制剤
ATE303144T1 (de) * 1995-11-17 2005-09-15 Univ Johns Hopkins Hemmung der fettsäuresynthase als mittel zur verminderung der adipozytenmenge
ATE330598T1 (de) * 1999-11-12 2006-07-15 Univ Johns Hopkins Behandlung von krebs durch erhöhung des malonyl- coa-spiegels
AU2001238515A1 (en) * 2000-02-16 2001-08-27 The John Hopkins University School Of Medicine Weight loss induced by reduction in neuropeptide y level

Also Published As

Publication number Publication date
EA200500122A1 (ru) 2005-12-29
HK1086485A1 (en) 2006-09-22
EA010484B1 (ru) 2008-10-30
WO2004006835A2 (en) 2004-01-22
JP2005533107A (ja) 2005-11-04
KR20050072670A (ko) 2005-07-12
BRPI0312413A2 (pt) 2016-08-02
CN100482219C (zh) 2009-04-29
CA2491183A1 (en) 2004-01-22
CN1705478A (zh) 2005-12-07
AU2003248810A1 (en) 2004-02-02
SG170620A1 (en) 2011-05-30
ZA200500203B (en) 2009-09-30
AU2003248810B2 (en) 2009-08-20
US20060241177A1 (en) 2006-10-26
CN101633650A (zh) 2010-01-27
WO2004006835A3 (en) 2004-07-22
EP1534263A2 (en) 2005-06-01
MXPA05000152A (es) 2005-10-24
EP1534263A4 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
IL173639A0 (en) Ppar-activating compound and pharmaceutical composition containing same
IL164987A0 (en) Proline derivatives and pharmaceutical compositions containing
IL164455A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
HUP0401711A3 (en) N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them
IL164185A0 (en) Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
IL174128A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0303724A3 (en) Chemokine receptors inhibitor bipiperidinyl-derivatives and pharmaceutical compositions containing them and process for preparation of the compounds
HUP0303193A3 (en) Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them
IL174249A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
EP1569915A4 (en) SPIROCYCLIC UREAS, COMPOSITIONS CONTAINING SAME, AND METHODS OF USE
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
AU2003222921A8 (en) Novel perindopril salt and pharmaceutical compositions containing same
PL1664050T3 (pl) Neuroprotekcyjne związki bicykliczne i zawierające je kompozycje farmaceutyczne
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
PL367128A1 (en) Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
PL361518A1 (en) Application of substance and pharmaceutical composition
IL165902A0 (en) Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them